BibTex RIS Cite

115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ

Year 2004, Volume: 35 Issue: 2, 0 - , 27.07.2014

Abstract

Background.- This study was conducted to evaluate complications associated with venous access devices used in long-term therapies in the cancer patients.

Methods.- One hundred and fifteen consequtive adult cancer patients in whom a subcutaneous port was inserted were evaluated retrospectively between 1996 and 2004.

Results- The total accrued sum of device-days for the 115 ports studied was 62,004 days, the average duration after placement was 539 days (range,8-2348 days), and the median duration was 382 days. Complications were identified in 11 of the 115 patients (9.5%). The average duration of ports in the complication group was 467 days (range, 8-1024 days) and median was 407 days. Complications included thrombosis (n:6; 5.1%) in which in one of the patients the catheter end was found in the right femoral vein instead of right atrium causing deep venous thrombosis, port infection (n:1; 0.8%), pneumothorax (n:1; 0.8%), mediastinal extravasation (n:1; 0.8%), port occlusion (n:1; 0.8%) and breaking of the catheter of the port (n:1; 0.8%). Port removal as a result of the complication was performed in 7 patients.

Conclusions.- The insertion technique and maintenance of sterility and safety is very important in long term intravenous access devices used in long term therapies in the cancer patients.

* Anahtar Kelimeler: Santral venöz portlar, venöz port komplikasyonları, kanser hastaları

* Key Words: Central venous access, venous port complications, cancer patients

Year 2004, Volume: 35 Issue: 2, 0 - , 27.07.2014

Abstract

There are 0 citations in total.

Details

Primary Language Turkish
Journal Section Araştırmalar
Authors

Tülay Samancı This is me

Nil Molinas Mandel This is me

A. Kürşat Bozkurt This is me

Fikret Kutlu This is me

Cihan Uras This is me

Publication Date July 27, 2014
Published in Issue Year 2004 Volume: 35 Issue: 2

Cite

APA Samancı, T., Molinas Mandel, N., Bozkurt, A. K., Kutlu, F., et al. (2014). 115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ. Cerrahpaşa Tıp Dergisi, 35(2).
AMA Samancı T, Molinas Mandel N, Bozkurt AK, Kutlu F, Uras C. 115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ. Cerrahpaşa Tıp Dergisi. August 2014;35(2).
Chicago Samancı, Tülay, Nil Molinas Mandel, A. Kürşat Bozkurt, Fikret Kutlu, and Cihan Uras. “115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ”. Cerrahpaşa Tıp Dergisi 35, no. 2 (August 2014).
EndNote Samancı T, Molinas Mandel N, Bozkurt AK, Kutlu F, Uras C (August 1, 2014) 115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ. Cerrahpaşa Tıp Dergisi 35 2
IEEE T. Samancı, N. Molinas Mandel, A. K. Bozkurt, F. Kutlu, and C. Uras, “115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ”, Cerrahpaşa Tıp Dergisi, vol. 35, no. 2, 2014.
ISNAD Samancı, Tülay et al. “115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ”. Cerrahpaşa Tıp Dergisi 35/2 (August 2014).
JAMA Samancı T, Molinas Mandel N, Bozkurt AK, Kutlu F, Uras C. 115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ. Cerrahpaşa Tıp Dergisi. 2014;35.
MLA Samancı, Tülay et al. “115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ”. Cerrahpaşa Tıp Dergisi, vol. 35, no. 2, 2014.
Vancouver Samancı T, Molinas Mandel N, Bozkurt AK, Kutlu F, Uras C. 115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ. Cerrahpaşa Tıp Dergisi. 2014;35(2).